| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 4/6 |
Neuberger Berman High Yield Strategies Fund Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.95 |
| 52 Week High | US$9.13 |
| 52 Week Low | US$6.95 |
| Beta | 0.97 |
| 1 Month Change | -0.25% |
| 3 Month Change | 1.02% |
| 1 Year Change | -12.83% |
| 3 Year Change | -36.90% |
| 5 Year Change | -32.91% |
| Change since IPO | -47.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| NHS | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | -1.6% | -2.6% | -3.7% |
| 1Y | -12.8% | 22.7% | 20.5% |
Return vs Industry: NHS underperformed the US Capital Markets industry which returned 22.2% over the past year.
Return vs Market: NHS underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| NHS volatility | |
|---|---|
| NHS Average Weekly Movement | 1.5% |
| Capital Markets Industry Average Movement | 3.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NHS has not had significant price volatility in the past 3 months.
Volatility Over Time: NHS's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | n/a | www.nb.com/Pages/Public/en-us/Products/high-yield-strategies-fund.aspx |
Neuberger Berman High Yield Strategies Fund Inc. is a closed-ended fixed income mutual fund launched by Neuberger Berman LLC. The fund is managed by Neuberger Berman Investment Advisers LLC. It invests in fixed income markets across the globe.
Neuberger Berman High Yield Strategies Fund Inc. Fundamentals Summary
| NHS fundamental statistics | |
|---|---|
| Market cap | US$204.09m |
| Earnings (TTM) | US$3.72m |
| Revenue (TTM) | US$22.35m |
55.5x
P/E Ratio9.2x
P/S RatioIs NHS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NHS income statement (TTM) | |
|---|---|
| Revenue | US$22.35m |
| Cost of Revenue | US$0 |
| Gross Profit | US$22.35m |
| Other Expenses | US$18.63m |
| Earnings | US$3.72m |
Last Reported Earnings
Oct 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.14 |
| Gross Margin | 100.00% |
| Net Profit Margin | 16.63% |
| Debt/Equity Ratio | 54.5% |
How did NHS perform over the long term?
See historical performance and comparison